BMEZ

BMEZ offers exposure to healthcare innovation but faces NAV instability and dividend sustainability concerns. Read why the BMEZ CEF is upgraded to hold.

Delaying Social Security to age 70 can boost benefits by up to 124%, but requires a robust interim income strategy.

BlackRock Health Sciences Term Trust returned +6.7% on market price and +8.6% on net asset value during Q4 2025. The STOXX Global Breakthrough Healthcare Index returned +9.9%.*

BlackRock Health Sciences Trust II trades at a 12.76% discount to NAV, near its deepest 1-year discount, but faces risks. Read more on BMEZ stock here.

NEW YORK, February 27, 2026--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), BlackRock

BlackRock Health Sciences Term Trust returned +4.7% on market price and +8.2% on net asset value during Q3 2025. Read more here.

BMEZ trades at a 12% discount after ending options writing and cutting its payout—learn what this means for biotech-heavy returns and income.

Discover if Amplify CEF High Income ETF (YYY) fits your income strategy.

See why BlackRock Health Sciences Trust is a Buy for income investors, offering an 8% yield, NAV discount, and resilient healthcare exposure. Click for more on BME.

BlackRock Health Sciences Term Trust is rated a Sell with unsustainable distributions and rapid NAV decline. Learn more about BMEZ CEF here.

NEW YORK,, November 14, 2025--The BlackRock closed-end funds listed below (each, a "Fund" and collectively, the "Funds") announced today the renewal of their discount management programs (each, a "Program" and collectively, the "Programs"). Under the terms of each Fund’s Program, each Fund intends to offer to repurchase a portion of its common shares via tender offer if certain conditions are met during the specified time period, as detailed below.

NEW YORK, September 11, 2025--The Board of Trustees (the "Board") of BlackRock Health Sciences Term Trust (BMEZ), BlackRock Science and Technology Term Trust (BSTZ), and BlackRock Technology and Private Equity Term Trust (BTX) (the "Funds") approved updates to each Fund’s managed distribution plan that will take effect with the October 2025 distribution. The Funds will change from a floating rate distribution to a level rate distribution at the stated monthly rates provided below. These changes

NEW YORK, September 10, 2025--The BlackRock Sector Equity Closed End Funds (CEFs) listed below (the "Funds") announced today that each Fund’s Board of Trustees (the "Board") has approved the following updates to the Funds’ respective investment objectives and principal investment strategies.

BMEZ trades at a 10% NAV discount with a high, unsustainable yield. Find out why I rate BMEZ stock a hold.

BlackRock reviews Q2 2025 results for BMEZ, highlighting private equity growth, option strategy, and sector shifts. Explore the full commentary for insights.

Discover insights on equity markets hitting all-time highs, narrowing CEF discounts, and smart reinvestment strategies.